Serious adverse drug reactions rare from certain treatment for vascular tumor in infants
Wednesday, January 27, 2016 - 13:03
in Health & Medicine
The safety of propranolol therapy in treating infantile hemangioma, a vascular tumor characterized by rapid growth during the first weeks of life, has been the focus of recent study. Severe forms require systemic therapy. Propranolol, a beta blocker, induces regression, but safety data have been lacking for children.